can a primary doctor prescribe glp 1 How Do I GLP-1 Agonists and to Whom? Safety, cost and more: The

iu ha cho qu trnh sn sinh cc cht prostaglandin, cytokine, protein v leucotrien

As a Doctor of Physical Therapy who is Dual Board Certified in Pelvic Health (WCS and PRPC), Ive worked with many patients facing these bowel challenges

For instance, in April 2025, Pfizer, a US-based pharmaceutical company specializing in metabolic and cardiometabolic drug development, provided an update on its oral GLP-1 receptor agonist candidate, danuglipron, following the completion of once-daily formulation studies intended to improve dosing convenience for patients

In cardiovascular outcome trials (CVOTs) such as Empagliflozin Cardiovascular Outcome Event Trial in Type 2 diabetes Mellitus Patients (EMPA-REG OUTCOME), CANagliflozin cardioVascular Assessment Study (CANVAS) and The Dapagliflozin Effect on Cardiovascular EventsThrombolysis in Myocardial Infarction 58 (DECLARE-TIMI 58) [6], they reduced the onset and progression of DKD, which was confirmed in the dedicated kidney trial The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE), which showed a canagliflozin-induced risk reduction for ESKD in people with DKD by 32% [7]

"GLP-1s are phenomenal medications